HEADER TRANSFERASE 27-FEB-17 5PZM TITLE CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA TITLE 2 POLYMERASE IN COMPLEX WITH 3-[2-(4-FLUOROPHENYL)-3-(METHYLCARBAMOYL)- TITLE 3 1-BENZOFURAN-5-YL]BENZOIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA-DIRECTED RNA POLYMERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.7.7.48; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS GENOTYPE 1B (ISOLATE CON1); SOURCE 3 ORGANISM_COMMON: HCV; SOURCE 4 ORGANISM_TAXID: 333284; SOURCE 5 STRAIN: ISOLATE CON1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21B KEYWDS NS5B, POLYMERASE, HCV, FINGERS, PALM, THUMB, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 4 06-MAR-24 5PZM 1 REMARK REVDAT 3 21-FEB-18 5PZM 1 REMARK REVDAT 2 14-JUN-17 5PZM 1 JRNL REVDAT 1 10-MAY-17 5PZM 0 JRNL AUTH K.S.YEUNG,B.R.BENO,K.PARCELLA,J.A.BENDER,K.A.GRANT-YOUNG, JRNL AUTH 2 A.NICKEL,P.GUNAGA,P.ANJANAPPA,R.O.BORA,K.SELVAKUMAR,K.RIGAT, JRNL AUTH 3 Y.K.WANG,M.LIU,J.LEMM,K.MOSURE,S.SHERIFF,C.WAN,M.WITMER, JRNL AUTH 4 K.KISH,U.HANUMEGOWDA,X.ZHUO,Y.Z.SHU,D.PARKER,R.HASKELL,A.NG, JRNL AUTH 5 Q.GAO,E.COLSTON,J.RAYBON,D.M.GRASELA,K.SANTONE,M.GAO, JRNL AUTH 6 N.A.MEANWELL,M.SINZ,M.G.SOARS,J.O.KNIPE,S.B.ROBERTS, JRNL AUTH 7 J.F.KADOW JRNL TITL DISCOVERY OF A HEPATITIS C VIRUS NS5B REPLICASE PALM SITE JRNL TITL 2 ALLOSTERIC INHIBITOR (BMS-929075) ADVANCED TO PHASE 1 JRNL TITL 3 CLINICAL STUDIES. JRNL REF J. MED. CHEM. V. 60 4369 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28430437 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00328 REMARK 2 REMARK 2 RESOLUTION. 2.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.07 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.8 REMARK 3 NUMBER OF REFLECTIONS : 43832 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.440 REMARK 3 FREE R VALUE TEST SET COUNT : 1069 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.54 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.61 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 54.67 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1896 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2150 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1854 REMARK 3 BIN R VALUE (WORKING SET) : 0.2150 REMARK 3 BIN FREE R VALUE : 0.2450 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 42 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8462 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 179 REMARK 3 SOLVENT ATOMS : 264 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.00240 REMARK 3 B22 (A**2) : 0.22180 REMARK 3 B33 (A**2) : 3.78060 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.310 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.556 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.269 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.535 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.270 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.902 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 8941 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 12239 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3030 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 161 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1450 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 8941 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1154 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 10455 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.97 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.41 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5PZM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1001401312. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43881 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.530 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.7 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06900 REMARK 200 FOR THE DATA SET : 21.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.53 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.62 REMARK 200 COMPLETENESS FOR SHELL (%) : 51.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.25400 REMARK 200 FOR SHELL : 4.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 3Q0Z REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM CITRATE, PH 5.6, 1.75 M REMARK 280 (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.25000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 116.10000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.80000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 116.10000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.25000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.80000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 15 REMARK 465 ALA A 16 REMARK 465 GLU A 17 REMARK 465 GLU A 18 REMARK 465 THR A 19 REMARK 465 LYS A 20 REMARK 465 LEU A 21 REMARK 465 PRO A 22 REMARK 465 ILE A 23 REMARK 465 ASN A 24 REMARK 465 ALA A 25 REMARK 465 LEU A 26 REMARK 465 SER A 27 REMARK 465 ASN A 28 REMARK 465 SER A 29 REMARK 465 LEU A 30 REMARK 465 LEU A 31 REMARK 465 ARG A 32 REMARK 465 HIS A 33 REMARK 465 HIS A 34 REMARK 465 ASN A 35 REMARK 465 LEU A 36 REMARK 465 MET B 0 REMARK 465 ALA B 15 REMARK 465 ALA B 16 REMARK 465 GLU B 17 REMARK 465 GLU B 18 REMARK 465 THR B 19 REMARK 465 LYS B 20 REMARK 465 LEU B 21 REMARK 465 PRO B 22 REMARK 465 ILE B 23 REMARK 465 ASN B 24 REMARK 465 ALA B 25 REMARK 465 LEU B 26 REMARK 465 SER B 27 REMARK 465 ASN B 28 REMARK 465 SER B 29 REMARK 465 LEU B 30 REMARK 465 LEU B 31 REMARK 465 ARG B 32 REMARK 465 HIS B 33 REMARK 465 HIS B 34 REMARK 465 ASN B 35 REMARK 465 LEU B 36 REMARK 465 ARG B 568 REMARK 465 PRO B 569 REMARK 465 ARG B 570 REMARK 465 TRP B 571 REMARK 465 PHE B 572 REMARK 465 MET B 573 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 57 CG CD1 CD2 REMARK 470 LYS A 100 CD CE NZ REMARK 470 VAL A 147 CG1 CG2 REMARK 470 GLN A 148 CG CD OE1 NE2 REMARK 470 GLU A 150 CG CD OE1 OE2 REMARK 470 LYS A 151 CG CD CE NZ REMARK 470 ARG A 154 CZ NH1 NH2 REMARK 470 LYS A 355 CE NZ REMARK 470 LYS A 535 CD CE NZ REMARK 470 ARG A 568 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 57 CG CD1 CD2 REMARK 470 LYS B 90 CD CE NZ REMARK 470 LYS B 100 CD CE NZ REMARK 470 VAL B 147 CG1 CG2 REMARK 470 GLN B 148 CD OE1 NE2 REMARK 470 GLU B 150 CG CD OE1 OE2 REMARK 470 LYS B 151 CG CD CE NZ REMARK 470 LYS B 355 CG CD CE NZ REMARK 470 ARG B 401 NE CZ NH1 NH2 REMARK 470 VAL B 405 CG1 CG2 REMARK 470 LYS B 535 CD CE NZ REMARK 470 ARG B 566 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 147 94.23 -67.60 REMARK 500 LYS A 151 49.21 -101.21 REMARK 500 LEU A 260 -56.50 -128.10 REMARK 500 SER A 347 66.35 65.70 REMARK 500 ALA A 348 59.21 -155.87 REMARK 500 LYS A 533 122.11 66.96 REMARK 500 LEU A 536 98.69 66.74 REMARK 500 VAL A 552 -61.14 -107.13 REMARK 500 TYR A 555 26.01 -142.88 REMARK 500 ARG A 568 65.89 62.93 REMARK 500 VAL B 147 94.07 -67.99 REMARK 500 LYS B 151 49.37 -101.03 REMARK 500 LEU B 260 -56.48 -129.57 REMARK 500 SER B 347 67.05 65.41 REMARK 500 ALA B 348 59.64 -156.25 REMARK 500 ILE B 424 -60.20 -104.14 REMARK 500 LEU B 536 96.39 67.27 REMARK 500 VAL B 552 -61.75 -107.03 REMARK 500 TYR B 555 25.85 -142.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 23E A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 23E B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8XS B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 607 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 608 DBREF 5PZM A 1 573 UNP Q9WMX2 POLG_HCVCO 2420 2992 DBREF 5PZM B 1 573 UNP Q9WMX2 POLG_HCVCO 2420 2992 SEQADV 5PZM MET A 0 UNP Q9WMX2 EXPRESSION TAG SEQADV 5PZM MET B 0 UNP Q9WMX2 EXPRESSION TAG SEQRES 1 A 574 MET SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR SEQRES 2 A 574 PRO CYS ALA ALA GLU GLU THR LYS LEU PRO ILE ASN ALA SEQRES 3 A 574 LEU SER ASN SER LEU LEU ARG HIS HIS ASN LEU VAL TYR SEQRES 4 A 574 ALA THR THR SER ARG SER ALA SER LEU ARG GLN LYS LYS SEQRES 5 A 574 VAL THR PHE ASP ARG LEU GLN VAL LEU ASP ASP HIS TYR SEQRES 6 A 574 ARG ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR SEQRES 7 A 574 VAL LYS ALA LYS LEU LEU SER VAL GLU GLU ALA CYS LYS SEQRES 8 A 574 LEU THR PRO PRO HIS SER ALA ARG SER LYS PHE GLY TYR SEQRES 9 A 574 GLY ALA LYS ASP VAL ARG ASN LEU SER SER LYS ALA VAL SEQRES 10 A 574 ASN HIS ILE ARG SER VAL TRP LYS ASP LEU LEU GLU ASP SEQRES 11 A 574 THR GLU THR PRO ILE ASP THR THR ILE MET ALA LYS ASN SEQRES 12 A 574 GLU VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS SEQRES 13 A 574 PRO ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG SEQRES 14 A 574 VAL CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR SEQRES 15 A 574 LEU PRO GLN ALA VAL MET GLY SER SER TYR GLY PHE GLN SEQRES 16 A 574 TYR SER PRO GLY GLN ARG VAL GLU PHE LEU VAL ASN ALA SEQRES 17 A 574 TRP LYS ALA LYS LYS CYS PRO MET GLY PHE ALA TYR ASP SEQRES 18 A 574 THR ARG CYS PHE ASP SER THR VAL THR GLU ASN ASP ILE SEQRES 19 A 574 ARG VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA SEQRES 20 A 574 PRO GLU ALA ARG GLN ALA ILE ARG SER LEU THR GLU ARG SEQRES 21 A 574 LEU TYR ILE GLY GLY PRO LEU THR ASN SER LYS GLY GLN SEQRES 22 A 574 ASN CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU SEQRES 23 A 574 THR THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS SEQRES 24 A 574 ALA ALA ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS SEQRES 25 A 574 THR MET LEU VAL CYS GLY ASP ASP LEU VAL VAL ILE CYS SEQRES 26 A 574 GLU SER ALA GLY THR GLN GLU ASP GLU ALA SER LEU ARG SEQRES 27 A 574 ALA PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO SEQRES 28 A 574 GLY ASP PRO PRO LYS PRO GLU TYR ASP LEU GLU LEU ILE SEQRES 29 A 574 THR SER CYS SER SER ASN VAL SER VAL ALA HIS ASP ALA SEQRES 30 A 574 SER GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR SEQRES 31 A 574 THR PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS SEQRES 32 A 574 THR PRO VAL ASN SER TRP LEU GLY ASN ILE ILE MET TYR SEQRES 33 A 574 ALA PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS SEQRES 34 A 574 PHE PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS SEQRES 35 A 574 ALA LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE SEQRES 36 A 574 GLU PRO LEU ASP LEU PRO GLN ILE ILE GLN ARG LEU HIS SEQRES 37 A 574 GLY LEU SER ALA PHE SER LEU HIS SER TYR SER PRO GLY SEQRES 38 A 574 GLU ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY SEQRES 39 A 574 VAL PRO PRO LEU ARG VAL TRP ARG HIS ARG ALA ARG SER SEQRES 40 A 574 VAL ARG ALA ARG LEU LEU SER GLN GLY GLY ARG ALA ALA SEQRES 41 A 574 THR CYS GLY LYS TYR LEU PHE ASN TRP ALA VAL ARG THR SEQRES 42 A 574 LYS LEU LYS LEU THR PRO ILE PRO ALA ALA SER GLN LEU SEQRES 43 A 574 ASP LEU SER SER TRP PHE VAL ALA GLY TYR SER GLY GLY SEQRES 44 A 574 ASP ILE TYR HIS SER LEU SER ARG ALA ARG PRO ARG TRP SEQRES 45 A 574 PHE MET SEQRES 1 B 574 MET SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR SEQRES 2 B 574 PRO CYS ALA ALA GLU GLU THR LYS LEU PRO ILE ASN ALA SEQRES 3 B 574 LEU SER ASN SER LEU LEU ARG HIS HIS ASN LEU VAL TYR SEQRES 4 B 574 ALA THR THR SER ARG SER ALA SER LEU ARG GLN LYS LYS SEQRES 5 B 574 VAL THR PHE ASP ARG LEU GLN VAL LEU ASP ASP HIS TYR SEQRES 6 B 574 ARG ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR SEQRES 7 B 574 VAL LYS ALA LYS LEU LEU SER VAL GLU GLU ALA CYS LYS SEQRES 8 B 574 LEU THR PRO PRO HIS SER ALA ARG SER LYS PHE GLY TYR SEQRES 9 B 574 GLY ALA LYS ASP VAL ARG ASN LEU SER SER LYS ALA VAL SEQRES 10 B 574 ASN HIS ILE ARG SER VAL TRP LYS ASP LEU LEU GLU ASP SEQRES 11 B 574 THR GLU THR PRO ILE ASP THR THR ILE MET ALA LYS ASN SEQRES 12 B 574 GLU VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS SEQRES 13 B 574 PRO ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG SEQRES 14 B 574 VAL CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR SEQRES 15 B 574 LEU PRO GLN ALA VAL MET GLY SER SER TYR GLY PHE GLN SEQRES 16 B 574 TYR SER PRO GLY GLN ARG VAL GLU PHE LEU VAL ASN ALA SEQRES 17 B 574 TRP LYS ALA LYS LYS CYS PRO MET GLY PHE ALA TYR ASP SEQRES 18 B 574 THR ARG CYS PHE ASP SER THR VAL THR GLU ASN ASP ILE SEQRES 19 B 574 ARG VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA SEQRES 20 B 574 PRO GLU ALA ARG GLN ALA ILE ARG SER LEU THR GLU ARG SEQRES 21 B 574 LEU TYR ILE GLY GLY PRO LEU THR ASN SER LYS GLY GLN SEQRES 22 B 574 ASN CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU SEQRES 23 B 574 THR THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS SEQRES 24 B 574 ALA ALA ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS SEQRES 25 B 574 THR MET LEU VAL CYS GLY ASP ASP LEU VAL VAL ILE CYS SEQRES 26 B 574 GLU SER ALA GLY THR GLN GLU ASP GLU ALA SER LEU ARG SEQRES 27 B 574 ALA PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO SEQRES 28 B 574 GLY ASP PRO PRO LYS PRO GLU TYR ASP LEU GLU LEU ILE SEQRES 29 B 574 THR SER CYS SER SER ASN VAL SER VAL ALA HIS ASP ALA SEQRES 30 B 574 SER GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR SEQRES 31 B 574 THR PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS SEQRES 32 B 574 THR PRO VAL ASN SER TRP LEU GLY ASN ILE ILE MET TYR SEQRES 33 B 574 ALA PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS SEQRES 34 B 574 PHE PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS SEQRES 35 B 574 ALA LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE SEQRES 36 B 574 GLU PRO LEU ASP LEU PRO GLN ILE ILE GLN ARG LEU HIS SEQRES 37 B 574 GLY LEU SER ALA PHE SER LEU HIS SER TYR SER PRO GLY SEQRES 38 B 574 GLU ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY SEQRES 39 B 574 VAL PRO PRO LEU ARG VAL TRP ARG HIS ARG ALA ARG SER SEQRES 40 B 574 VAL ARG ALA ARG LEU LEU SER GLN GLY GLY ARG ALA ALA SEQRES 41 B 574 THR CYS GLY LYS TYR LEU PHE ASN TRP ALA VAL ARG THR SEQRES 42 B 574 LYS LEU LYS LEU THR PRO ILE PRO ALA ALA SER GLN LEU SEQRES 43 B 574 ASP LEU SER SER TRP PHE VAL ALA GLY TYR SER GLY GLY SEQRES 44 B 574 ASP ILE TYR HIS SER LEU SER ARG ALA ARG PRO ARG TRP SEQRES 45 B 574 PHE MET HET 23E A 601 85 HET SO4 A 602 5 HET SO4 A 603 5 HET SO4 A 604 5 HET SO4 A 605 5 HET SO4 A 606 5 HET 23E B 601 85 HET 8XS B 602 45 HET SO4 B 603 5 HET SO4 B 604 5 HET SO4 B 605 5 HET SO4 B 606 5 HET SO4 B 607 5 HET GOL B 608 6 HETNAM 23E (2E)-3-(4-{[(1-{[(13-CYCLOHEXYL-6-OXO-6,7-DIHYDRO-5H- HETNAM 2 23E INDOLO[1,2-D][1,4]BENZODIAZEPIN-10-YL) HETNAM 3 23E CARBONYL]AMINO}CYCLOPENTYL)CARBONYL]AMINO}PHENYL)PROP- HETNAM 4 23E 2-ENOIC ACID HETNAM SO4 SULFATE ION HETNAM 8XS 3-[2-(4-FLUOROPHENYL)-3-(METHYLCARBAMOYL)-1-BENZOFURAN- HETNAM 2 8XS 5-YL]BENZOIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 23E 2(C38 H38 N4 O5) FORMUL 4 SO4 10(O4 S 2-) FORMUL 10 8XS C23 H16 F N O4 FORMUL 16 GOL C3 H8 O3 FORMUL 17 HOH *264(H2 O) HELIX 1 AA1 THR A 41 ARG A 43 5 3 HELIX 2 AA2 SER A 44 THR A 53 1 10 HELIX 3 AA3 ASP A 61 SER A 76 1 16 HELIX 4 AA4 SER A 84 LEU A 91 1 8 HELIX 5 AA5 GLY A 104 ASN A 110 1 7 HELIX 6 AA6 SER A 112 ASP A 129 1 18 HELIX 7 AA7 ASP A 164 GLY A 188 1 25 HELIX 8 AA8 SER A 189 TYR A 195 5 7 HELIX 9 AA9 SER A 196 ALA A 210 1 15 HELIX 10 AB1 CYS A 223 VAL A 228 1 6 HELIX 11 AB2 THR A 229 GLN A 241 1 13 HELIX 12 AB3 ALA A 246 LEU A 260 1 15 HELIX 13 AB4 THR A 286 ALA A 306 1 21 HELIX 14 AB5 GLY A 328 TYR A 346 1 19 HELIX 15 AB6 ASP A 359 ILE A 363 5 5 HELIX 16 AB7 PRO A 388 ARG A 401 1 14 HELIX 17 AB8 ASN A 406 TYR A 415 1 10 HELIX 18 AB9 THR A 418 ILE A 424 1 7 HELIX 19 AC1 ILE A 424 GLU A 437 1 14 HELIX 20 AC2 GLU A 455 LEU A 457 5 3 HELIX 21 AC3 ASP A 458 GLY A 468 1 11 HELIX 22 AC4 LEU A 469 SER A 473 5 5 HELIX 23 AC5 SER A 478 GLY A 493 1 16 HELIX 24 AC6 PRO A 496 SER A 513 1 18 HELIX 25 AC7 GLY A 515 PHE A 526 1 12 HELIX 26 AC8 ILE A 539 SER A 543 5 5 HELIX 27 AC9 THR B 41 ARG B 43 5 3 HELIX 28 AD1 SER B 44 THR B 53 1 10 HELIX 29 AD2 ASP B 61 SER B 76 1 16 HELIX 30 AD3 SER B 84 LEU B 91 1 8 HELIX 31 AD4 GLY B 104 ASN B 110 1 7 HELIX 32 AD5 SER B 112 ASP B 129 1 18 HELIX 33 AD6 ASP B 164 GLY B 188 1 25 HELIX 34 AD7 SER B 189 TYR B 195 5 7 HELIX 35 AD8 SER B 196 ALA B 210 1 15 HELIX 36 AD9 CYS B 223 VAL B 228 1 6 HELIX 37 AE1 THR B 229 GLN B 241 1 13 HELIX 38 AE2 ALA B 246 LEU B 260 1 15 HELIX 39 AE3 THR B 286 ALA B 306 1 21 HELIX 40 AE4 GLY B 328 TYR B 346 1 19 HELIX 41 AE5 ASP B 359 ILE B 363 5 5 HELIX 42 AE6 PRO B 388 ARG B 401 1 14 HELIX 43 AE7 ASN B 406 ALA B 416 1 11 HELIX 44 AE8 THR B 418 ILE B 424 1 7 HELIX 45 AE9 ILE B 424 GLU B 437 1 14 HELIX 46 AF1 GLU B 455 LEU B 457 5 3 HELIX 47 AF2 ASP B 458 GLY B 468 1 11 HELIX 48 AF3 LEU B 469 SER B 473 5 5 HELIX 49 AF4 SER B 478 GLY B 493 1 16 HELIX 50 AF5 PRO B 496 SER B 513 1 18 HELIX 51 AF6 GLY B 515 PHE B 526 1 12 HELIX 52 AF7 ILE B 539 SER B 543 5 5 SHEET 1 AA1 5 TYR A 4 TRP A 6 0 SHEET 2 AA1 5 ASN A 273 ARG A 277 -1 O TYR A 276 N THR A 5 SHEET 3 AA1 5 GLY A 264 THR A 267 -1 N LEU A 266 O GLY A 275 SHEET 4 AA1 5 THR A 136 ALA A 140 1 N ILE A 138 O THR A 267 SHEET 5 AA1 5 LEU A 159 PRO A 163 -1 O ILE A 160 N MET A 139 SHEET 1 AA2 2 TYR A 38 ALA A 39 0 SHEET 2 AA2 2 VAL A 144 PHE A 145 -1 O PHE A 145 N TYR A 38 SHEET 1 AA3 3 PRO A 214 TYR A 219 0 SHEET 2 AA3 3 ASP A 319 GLU A 325 -1 O CYS A 324 N MET A 215 SHEET 3 AA3 3 GLN A 309 CYS A 316 -1 N THR A 312 O ILE A 323 SHEET 1 AA4 2 SER A 368 HIS A 374 0 SHEET 2 AA4 2 ARG A 380 ARG A 386 -1 O THR A 385 N ASN A 369 SHEET 1 AA5 3 LEU A 443 ILE A 447 0 SHEET 2 AA5 3 ALA A 450 ILE A 454 -1 O TYR A 452 N CYS A 445 SHEET 3 AA5 3 TYR A 561 SER A 563 1 O HIS A 562 N CYS A 451 SHEET 1 AA6 2 LEU A 545 ASP A 546 0 SHEET 2 AA6 2 SER A 565 ARG A 566 -1 O SER A 565 N ASP A 546 SHEET 1 AA7 5 TYR B 4 TRP B 6 0 SHEET 2 AA7 5 ASN B 273 ARG B 277 -1 O TYR B 276 N THR B 5 SHEET 3 AA7 5 GLY B 264 THR B 267 -1 N GLY B 264 O ARG B 277 SHEET 4 AA7 5 THR B 136 ALA B 140 1 N ILE B 138 O THR B 267 SHEET 5 AA7 5 LEU B 159 PHE B 162 -1 O ILE B 160 N MET B 139 SHEET 1 AA8 2 TYR B 38 ALA B 39 0 SHEET 2 AA8 2 VAL B 144 PHE B 145 -1 O PHE B 145 N TYR B 38 SHEET 1 AA9 3 PRO B 214 TYR B 219 0 SHEET 2 AA9 3 ASP B 319 GLU B 325 -1 O CYS B 324 N MET B 215 SHEET 3 AA9 3 GLN B 309 CYS B 316 -1 N THR B 312 O ILE B 323 SHEET 1 AB1 2 SER B 368 HIS B 374 0 SHEET 2 AB1 2 ARG B 380 ARG B 386 -1 O VAL B 381 N ALA B 373 SHEET 1 AB2 3 LEU B 443 ILE B 447 0 SHEET 2 AB2 3 ALA B 450 ILE B 454 -1 O ILE B 454 N LEU B 443 SHEET 3 AB2 3 TYR B 561 SER B 563 1 O HIS B 562 N CYS B 451 SITE 1 AC1 12 LEU A 392 ALA A 396 HIS A 428 LEU A 492 SITE 2 AC1 12 GLY A 493 VAL A 494 PRO A 495 ARG A 498 SITE 3 AC1 12 VAL A 499 ARG A 503 23E B 601 HOH B 748 SITE 1 AC2 5 SER A 84 VAL A 85 GLU A 86 ARG A 120 SITE 2 AC2 5 HOH A 763 SITE 1 AC3 5 ARG A 48 LYS A 51 ARG A 222 CYS A 223 SITE 2 AC3 5 HOH A 743 SITE 1 AC4 5 HIS A 374 SER A 476 GLY A 516 ARG A 517 SITE 2 AC4 5 HOH A 756 SITE 1 AC5 5 PRO A 496 LEU A 497 ARG A 498 ARG A 570 SITE 2 AC5 5 HOH A 783 SITE 1 AC6 5 GLU A 361 SER A 371 SER A 478 LYS A 523 SITE 2 AC6 5 HOH A 771 SITE 1 AC7 17 ALA A 400 ARG A 401 HIS A 428 23E A 601 SITE 2 AC7 17 LEU B 392 ALA B 396 HIS B 428 LEU B 492 SITE 3 AC7 17 GLY B 493 VAL B 494 PRO B 495 ARG B 498 SITE 4 AC7 17 VAL B 499 ARG B 503 HOH B 748 HOH B 773 SITE 5 AC7 17 HOH B 789 SITE 1 AC8 14 ARG B 200 LEU B 204 LEU B 314 CYS B 316 SITE 2 AC8 14 ASP B 319 VAL B 321 ILE B 363 SER B 365 SITE 3 AC8 14 CYS B 366 SER B 368 LEU B 384 MET B 414 SITE 4 AC8 14 TYR B 448 HOH B 728 SITE 1 AC9 4 SER B 84 VAL B 85 GLU B 86 ARG B 120 SITE 1 AD1 3 GLY B 516 ARG B 517 HOH B 752 SITE 1 AD2 3 SER A 1 LYS B 379 ARG B 380 SITE 1 AD3 3 HIS B 475 SER B 476 HOH B 759 SITE 1 AD4 6 ARG B 48 LYS B 51 ARG B 158 THR B 221 SITE 2 AD4 6 ARG B 222 CYS B 223 SITE 1 AD5 4 ASN B 406 TRP B 408 LEU B 433 GLN B 436 CRYST1 66.500 91.600 232.200 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015038 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010917 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004307 0.00000